SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-093669
Filing Date
2023-08-21
Accepted
2023-08-21 07:01:06
Documents
14
Period of Report
2023-08-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2324228d1_8k.htm   iXBRL 8-K 30503
2 EXHIBIT 99.1 tm2324228d1_ex99-1.htm EX-99.1 10764
6 GRAPHIC tm2324228d1_ex99-1img001.jpg GRAPHIC 3484
  Complete submission text file 0001104659-23-093669.txt   224473

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fold-20230817.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20230817_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20230817_pre.xml EX-101.PRE 22379
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2324228d1_8k_htm.xml XML 3208
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 231187311
SIC: 2834 Pharmaceutical Preparations